Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
2.390
+0.070 (3.02%)
At close: Nov 4, 2024, 4:00 PM
2.400
+0.010 (0.42%)
After-hours: Nov 4, 2024, 4:34 PM EST
Oramed Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2020 |
| Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Aug '21 Aug 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 97 | 93 | 471 | 544 | 640 | 110 | |
| Market Cap Growth | -27.13% | -80.20% | -13.48% | -15.00% | 479.35% | 34.51% | |
| Enterprise Value | -58 | -9 | 311 | 444 | 565 | 67 | |
| Last Close Price | 2.39 | 2.31 | 12.03 | 14.28 | 19.68 | 4.24 | |
| PE Ratio | 4.72 | 16.86 | -12.80 | -15.14 | -25.19 | -4.71 | |
| PS Ratio | - | 69.54 | 174.08 | 200.54 | 236.73 | 40.73 | |
| PB Ratio | 0.55 | 0.57 | 3.11 | 3.26 | 5.49 | - | |
| P/FCF Ratio | -67.41 | -8.83 | -16.56 | -16.29 | -29.68 | -4.29 | |
| P/OCF Ratio | -69.06 | -9.05 | -16.85 | -16.30 | -30.21 | -4.46 | |
| EV/Sales Ratio | - | -6.93 | 115.15 | 163.83 | 208.87 | 24.59 | |
| EV/EBITDA Ratio | 3.36 | 0.60 | -7.68 | -12.03 | -23.38 | -2.94 | |
| EV/EBIT Ratio | 3.31 | 0.59 | -7.67 | -12.02 | -23.31 | -2.94 | |
| EV/FCF Ratio | 27.48 | 0.88 | -10.95 | -13.31 | -26.19 | -2.59 | |
| Debt / Equity Ratio | 0.00 | 0.32 | 0.01 | 0.00 | 0.00 | - | |
| Debt / FCF Ratio | -0.31 | -4.89 | -0.03 | -0.01 | -0.02 | - | |
| Asset Turnover | - | 0.01 | 0.02 | - | 0.03 | - | |
| Quick Ratio | 40.92 | 3.05 | 27.10 | 19.85 | 14.09 | - | |
| Current Ratio | 41.06 | 3.06 | 27.34 | 20.08 | 14.27 | - | |
| Return on Equity (ROE) | 12.70% | 3.24% | -23.77% | - | -30.78% | - | |
| Return on Assets (ROA) | -4.72% | -5.16% | -14.95% | - | -17.54% | - | |
| Return on Capital (ROIC) | -4.90% | -5.38% | -15.90% | - | -20.19% | - | |
| Earnings Yield | 21.41% | 5.93% | -7.77% | -6.44% | -3.48% | -19.89% | |
| FCF Yield | -1.59% | -11.32% | -6.04% | -6.14% | -3.37% | -23.31% | |
| Buyback Yield / Dilution | -3.79% | -4.02% | -5.08% | -30.36% | -16.71% | -18.81% | |
| Total Shareholder Return | -3.79% | -4.02% | -5.08% | -30.36% | -16.71% | -18.81% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.